Zivo Bioscience (NASDAQ:ZIVO) said on Thursday that the biotech company is set to effect a 1-for-6 reverse stock split to regain compliance with Nasdaq's listing requirements.
The reverse stock split is effective 5 PM ET today.
The company's board has approved the reverse stock split.
The new CUSIP number for the shares is US98978N3098.
The reverse stock split will reduce the number of Zivo Bioscience's authorized shares from 150M to 25M.